Overview of Specialty

The Uro-Oncology Department at Yashoda Medicity is dedicated to the prevention, diagnosis, and advanced treatment of cancers affecting the urinary system and male reproductive organs. Our specialists work across disciplines to provide holistic and personalized care, addressing cancers of the kidney, bladder, prostate, testis, adrenal glands, and ureters.

With expertise in both minimally invasive and complex open surgeries, supported by robotic and laparoscopic technology, we focus on delivering maximum tumor clearance while preserving function, continence, and quality of life. Our multidisciplinary tumor board ensures that each patient receives a treatment plan tailored to their condition and overall health.

Conditions Treated

We manage a wide spectrum of urological cancers, including:

  • Kidney Cancer (Renal Cell Carcinoma) – Tumors of the kidney treated with partial or radical nephrectomy, including nephron-sparing surgery.
  • Bladder Cancer – Managed with transurethral resection, radical cystectomy, bladder reconstruction, and intravesical therapies.
  • Prostate Cancer – Early-stage and advanced disease treated with robotic prostatectomy, radiation, or hormone therapy.
  • Testicular Cancer – Orchiectomy and advanced multimodal management for germ cell tumors.
  • Ureteric and Pelvic Tumors – Specialized surgical management for upper tract urothelial cancers.

Treatment Options

We offer comprehensive treatment modalities, blending advanced surgery with systemic and supportive therapies:

  • Robotic & Laparoscopic Surgery – For prostate, kidney, and bladder cancers, ensuring precision and faster recovery.
  • Targeted & Immunotherapy – Latest drug therapies tailored to cancer’s genetic and molecular profile.
  • Multidisciplinary Care – Integration of surgery, medical oncology, radiation therapy, and supportive care.

Patient Testimonials

Frequently Asked Questions

Uro-oncology is the specialized field of medicine that deals with cancers of the urinary tract and male reproductive system, including the kidney, bladder, prostate, testis, and adrenal glands.

Blood in urine, difficulty in urination, pelvic pain, testicular lumps, or unexplained weight loss may be signs that require medical evaluation.

Depending on the stage, treatment may include minimally invasive surgery, robotic-assisted surgery, radiation therapy, chemotherapy, or intravesical therapy.

Robotic surgeries provide enhanced precision, less blood loss, smaller incisions, faster recovery, and improved functional outcomes compared to open surgery, particularly in prostate and kidney cancers.

Yes, recurrence is possible. This is why long-term surveillance with imaging, cystoscopy, or lab tests is a critical part of follow-up care.
t>